We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Global Urinalysis Market Projected to Reach Nearly USD 5 Billion by 2026

By LabMedica International staff writers
Posted on 24 Aug 2021
The global urinalysis market is projected to grow at a CAGR of 7.2% from USD 3.5 billion in 2021 to nearly USD 4.9 billion by 2026, driven by the increasing burden of UTIs, diabetes, and kidney & liver diseases; rising geriatric population and subsequent increase in age-associated diseases, and growing adoption of POC diagnostic tests.

These are the latest findings of MarketsandMarkets (Northbrook, IL, USA), a global market research company.

Based on product, the consumables segment accounted for the largest share of the urinalysis market in 2020 due to frequent purchase of these products as a result of their recurrent usage. More...
Based on test type, the sediment urinalysis segment recorded the highest growth in 2020 which can be primarily attributed to the increasing adoption of automated devices for sediment analysis. Based on application, the disease screening segment held the largest share of the urinalysis market in 2020 due to increasing incidence of UTIs, diabetes, liver diseases and kidney ailments worldwide. Based on end user, diagnostic laboratories accounted for the largest share of the urinalysis market in 2020 owing to the rapidly growing aging population, rising global incidence of kidney diseases and UTIs, increase in reimbursements for clinical tests performed in hospitals and the launch of advanced urinalysis devices such as integrated devices.

Geographically, North America held the largest share of the global market urinalysis market in 2020 which can be attributed to the growing geriatric population, implementation of favorable government initiatives, increasing healthcare expenditure, improved healthcare infrastructure, and availability of technologically-advanced instruments in the region.

Related Links:
MarketsandMarkets


New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
New
Chlamydia Trachomatis Test
Aptima Chlamydia Trachomatis Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.